WHO Recommends Second Malaria Vaccine For Children

The World Health Organization announced Monday that its experts have recommended R21/Matrix-M, a malaria vaccine developed by Britain’s Oxford University, as a second malaria vaccination for children.

ALSO READ:  WHO Regrets President Trump De-funding Decision

The Serum Institute of India manufactures the R21/Matrix-M vaccine, which has previously been approved for use in Burkina Faso, Ghana, and Nigeria.

“As a malaria researcher, I used to dream of the day we would have a safe and effective vaccine against malaria. Now we have two,” said WHO chief Tedros Adhanom Ghebreyesus.

In 2021, the RTS,S vaccine, produced by British pharmaceutical giant GSK, became the first to be recommended by the WHO to prevent malaria in children in areas with moderate to high malaria transmission.

The WHO’s regional director for Africa, Dr Matshidiso Moeti, said the new vaccine held great potential for the continent by helping to close the huge demand-and-supply gap.

“Delivered to scale and rolled out widely, the two vaccines can help bolster malaria prevention and control efforts and save hundreds of thousands of young lives in Africa from this deadly disease,” she said.

Liverpool Ask For VAR Audio After Disallowed Goal

France To Vaccinate Millions Of Ducks Against Bird Flu